ASCO helps shape the regulatory framework in which oncologists practice by reviewing and commenting on a wide range of rules, guidelines, and system changes issued by federal agencies, including the U.S. Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and the Office of the National Coordinator for Health Information Technology (ONC). In recent months, the society has submitted comments in the following areas:
To view the comments and read the latest news on ASCO’s policy and quality efforts, please visit: www.asco.org/advocacy. ■
© 2013. American Society of Clinical Oncology. All rights reserved.